Maia
Miguelez
Dr. Maia Miguelez is a scientific expert specializing in psychiatry and neuroscience, who recently joined the Clinique Médicale 360 team as Vice President of Operations and Scientific Development.
Dr. Miguelez holds a PhD in Neuroscience from the University of Ottawa and a post-doctorate in Neuroimmunology from Carleton University. With nearly 20 years of experience in pharmaceutical development at companies such as Bristol-Myers Squibb, Merck, and Otsuka, she has played a key role in launching new drugs in psychiatry and immunology and co-authored over 50 scientific articles. Through her professional career, Dr. Miguelez has gained expertise in corporate governance and has been recognized for her strategic thinking and warm leadership in the national and international teams she has assembled and led.
In her role at Clinique 360, Dr. Miguelez is responsible for establishing an organizational and operational structure aimed at optimizing the functioning, efficiency, and expansion capacity of operations. She also oversees the development of human resources within the company as well as personnel management. As a specialist in neuroscience and psychiatry, she is also responsible for the development of the new mental health clinic (Ogilvy).
Passionate about science, medicine, and people, Dr. Miguelez is fully committed to leveraging her medical and governance skills to serve the continuous growth of Clinique 360, as well as to improve the health and well-being of the clinic’s employees, associates, and patients.
Languages spoken: French, English, and Spanish